Metagenomi, Inc. Common Stock Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.46 | -$0.38 | -$0.84 |
| Q2 2024 | 1 | -$1.14 | -$0.29 | -$0.65 |
| Q3 2024 | 1 | -$1.36 | -$0.35 | -$0.78 |
| Q4 2024 | 3 | -$0.99 | -$0.50 | -$0.75 |
| Q1 2025 | 2 | -$0.72 | -$0.68 | -$0.70 |
| Q2 2025 | 1 | -$1.30 | -$0.33 | -$0.74 |
| Q3 2025 | 1 | -$1.39 | -$0.36 | -$0.80 |
| Q4 2025 | 1 | -$1.43 | -$0.37 | -$0.82 |
| Q1 2026 | 1 | -$1.67 | -$0.43 | -$0.95 |
| Q2 2026 | 1 | -$1.67 | -$0.43 | -$0.95 |
| Q3 2026 | 1 | -$1.81 | -$0.47 | -$1.03 |
| Q4 2026 | 1 | -$1.81 | -$0.47 | -$1.03 |
Metagenomi, Inc. Common Stock Earnings Date And Information
Metagenomi, Inc. Common Stock last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.29 earnings per share for the quarter, topping analysts' consensus estimates of $-0.59 by $0.3. The company had revenue of 11.51 M for the quarter and had revenue of 44.76 M for the year. Metagenomi, Inc. Common Stock has generated $-2 earnings per share over the last year ($-1.82 diluted earnings per share) and currently has a price-to-earnings ratio of -0.94. Metagenomi, Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
Metagenomi, Inc. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | -$0.51 | $6.76 M | $11.51 M | ||
| 06/28/2024 | Q2 2024 | -$0.29 | $12.65 M | $20.01 M | ||
| 03/30/2024 | Q1 2024 | -$1.19 | $11.16 M | |||
| 12/30/2023 | Q4 2023 | -$0.51 | $12.40 M | |||
| 09/29/2023 | Q3 2023 | -$0.53 | $12.36 M | |||
| 06/29/2023 | Q2 2023 | -$0.39 | $11.34 M | |||
| 03/30/2023 | Q1 2023 | -$0.54 | $8.66 M | |||
| 12/30/2022 | Q4 2022 | -$0.39 | $5.60 M | |||
| 09/28/2022 | Q3 2022 | -$0.28 | $4.91 M |
Metagenomi, Inc. Common Stock Earnings: Frequently Asked Questions
-
When is Metagenomi, Inc. Common Stock's earnings date?
Metagenomi, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.
-
Did Metagenomi, Inc. Common Stock beat their earnings estimates last quarter?
In the previous quarter, Metagenomi, Inc. Common Stock (:MGX) reported $-0.29 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.59 by $0.3.
-
How can I listen to Metagenomi, Inc. Common Stock's earnings conference call?
The conference call for Metagenomi, Inc. Common Stock's latest earnings report can be listened to online.
-
How can I read Metagenomi, Inc. Common Stock's conference call transcript?
The conference call transcript for Metagenomi, Inc. Common Stock's latest earnings report can be read online.
-
How much revenue does Metagenomi, Inc. Common Stock generate each year?
Metagenomi, Inc. Common Stock (:MGX) has a recorded annual revenue of $44.76 M.
-
How much profit does Metagenomi, Inc. Common Stock generate each year?
Metagenomi, Inc. Common Stock (:MGX) has a recorded net income of $44.76 M. Metagenomi, Inc. Common Stock has generated $-1.82 earnings per share over the last four quarters.
-
What is Metagenomi, Inc. Common Stock's price-to-earnings ratio?
Metagenomi, Inc. Common Stock (:MGX) has a price-to-earnings ratio of -0.94 and price/earnings-to-growth ratio is -1.18.
